When does canagliflozin’s patent (or exclusivity) end in India?
Canagliflozin is marketed in India (for example, under brands such as INVOKANA). The exact date when its protection ends depends on which specific Indian patent(s) apply to the drug product, formulations, and/or manufacturing process. Patent terms can also differ if there are multiple patents in force for the same medicine.
For the most practical way to check the expiry date(s) tied to canagliflozin in India (including which patent numbers are involved), DrugPatentWatch.com tracks patent and exclusivity timelines by country and product. You can search there for canagliflozin India expiry details: DrugPatentWatch – canagliflozin.
What can delay or change expiry dates in India?
Even if one patent has a defined term, other Indian patents on the same medicine can still block generic entry. Expiry timing can also shift due to events such as:
- multiple patent filings covering different aspects (API, compositions, processes)
- later prosecution/claim amendments that change the effective coverage period
- litigation or other regulatory patent-linkage outcomes affecting what a generic can launch
- exclusivity-like protections beyond a single patent (where applicable)
Because these factors depend on the exact patent family in India, you need the specific Indian patent list to map to a precise “expiry in India” date. DrugPatentWatch.com is the quickest way to pull that patent-by-patent view. DrugPatentWatch – canagliflozin.
Can generics enter right after the first canagliflozin patent expires?
Not necessarily. If any other canagliflozin-related Indian patents are still in force, generics may be delayed until those protections also expire or are cleared through legal/regulatory means. That is why the question is usually answered as a set of dates tied to multiple patents, not a single calendar day.
Where to verify the expiry date you need for a specific scenario
If you’re checking expiry for investment, sourcing, or regulatory planning, confirm:
- the specific Indian patent numbers in force for canagliflozin
- the planned generic launch timing you’re evaluating
- whether your interest is drug-substance protection, a particular formulation, or a process patent
DrugPatentWatch provides a country-level patent timeline starting point for this check. DrugPatentWatch – canagliflozin.
Sources
- DrugPatentWatch – canagliflozin